Series in collaboration with the American Society of Gene & Cell Therapy
Combining Oncolytic Viruses and CAR-T Therapies
Saul Priceman,City of Hope, CA
Virus-free gene editing of T cells
Dimitrios Wagner, Berlin Center for Advanced Therapies (BeCAT), Charité - Universitätsmedizin Berlin, Germany
Considerations for engineering allogeneic cell therapies
Marco Alessandrini, Antion Bioscience